Temenos ranked #1 in 13 categories in the IBSi Sales League table, including core, digital, payments and wealthGRAND-LANCY, Switzerland, June 13, 2025 (GLOBE NEWSWIRE) -- Temenos (SIX: TEMN), a global leader in banking technology, today announced it has been recognized as the #1 best-selling software provider in 13 categories in the IBSi Sales League Table (SLT) 2025. Temenos ranked #1 for core banking for the 20th consecutive year, while also topping the table for categories covering digital, payments, wea ...

Amazon (AMZN -0.08%) announced several new artificial intelligence (AI) initiatives this month. While much of the investor focus when it comes to AI and Amazon has been on Amazon Web Services (AWS) and its cloud computing AI offerings, Amazon is also looking to use AI to improve its e-commerce business.The company has been laying the groundwork to use AI as a way to improve efficiency across its logistics and warehouse networks. Let's look at how these moves could be a game changer for the stock. New AI ini ...

Knut-Harald Bakke has been appointed EVP BioSolutions, effective 1 August 2025. He will also join the Group Executive Management on the same date. Bakke succeeds Tom Erik Foss-Jacobsen, who will assume the role of CEO on 1 August (see stock exchange release dated 23 May 2025). Bakke currently serves as Director of Investor Relations and has previously held the position of Energy Director at Borregaard. Prior to joining the company in 2019, he held senior leadership roles at Norsk Hydro, where he was respons ...

A high-octane company outside of the tech sector will be completing its first-ever forward stock split in the coming days.For more than three decades, investors have almost always had a next-big-thing trend or innovation to hold their attention. It started with the advent and proliferation of the internet in the mid-1990s and was followed by genome decoding, business-to-business e-commerce, nanotechnology, 3D printing, blockchain technology, cannabis, and the metaverse. Today, artificial intelligence (AI) i ...

After only a couple of months on the stock market, CoreWeave (CRWV -0.68%) already has made its mark. This is thanks to the company's close ties with artificial intelligence (AI) superpower Nvidia (NVDA 1.45%) and its own soaring levels of revenue in recent times. Investors looking for the next big AI growth story clearly have their eyes on CoreWeave.The company's initial public offering (IPO) fell flat in its first days, but it's important to keep in mind the timing of this event. It happened in late March ...

Citigroup (C -0.19%) is a popular U.S. bank with an attractive 2.8% yield. But what if you could get more than twice that yield without taking on a huge amount of risk? That's exactly what I did when I doubled my position in this Canadian banking giant. The trigger for my investment was the company's return to dividend growth with a 4% hike announced after it reported earnings for its fiscal second quarter of 2025. Here's why you might want to follow along if you have $25,000, or even just $500, to invest.W ...

Thawatchai Chawong The following data is derived from trading activity on the Tradeweb Markets institutional European- and U.S.-listed ETF platforms. European-Listed ETFs Total traded volume Trading activity on the Tradeweb European ETF marketplace amounted to EUR 62 billion in ...

Company Overview - United Therapeutics (UTHR) shares increased by 3.5% to close at $286.14, following a period of decline where the stock lost 7.7% over the past four weeks [1] - The rise in share price is linked to a recovery after a decline due to positive results from a pulmonary arterial hypertension (PAH) study conducted by Insmed, which evaluated a prodrug formulation of UTHR's treprostinil [2] Financial Performance - United Therapeutics is expected to report quarterly earnings of $6.87 per share, reflecting a year-over-year increase of 17.4% [3] - Revenue projections for the upcoming quarter stand at $796.42 million, which is an 11.4% increase compared to the same quarter last year [3] Earnings Estimates and Market Sentiment - The consensus EPS estimate for United Therapeutics has been revised 0.7% higher in the last 30 days, indicating a positive trend that typically correlates with stock price appreciation [4] - The company currently holds a Zacks Rank of 3 (Hold), suggesting a neutral outlook in the market [4] Industry Context - United Therapeutics operates within the Zacks Medical - Drugs industry, where BioCryst Pharmaceuticals (BCRX) is another player, having closed 2% lower at $10.40 [4] - BioCryst's consensus EPS estimate remains unchanged at $0.02, representing a significant year-over-year change of 133.3% [5]

Palantir Technologies (PLTR -0.97%) has created astounding wealth for shareholders in a very short period. It was the best-performing member of the S&P 500 (^GSPC 0.38%) last year, and the company is leading the index higher again this year. In total, Palantir stock has returned 695% since January 2024 and 2,000% since January 2023.However, Palantir is also the most expensive stock in the S&P 500, as measured by price-to-sales ratio. In fact, it is one of the most expensive software stocks in recent history ...

Valuation and Performance - LexinFintech's valuation has increased from 2x forward P/E to 4x forward earnings over the past year, indicating a significant multiples expansion [1] - This multiples expansion, along with net income growth, has led to a remarkable increase in share price [1]